A detailed history of Pgim Custom Harvest LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pgim Custom Harvest LLC holds 1,134 shares of VRTX stock, worth $560,887. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,134
Previous 700 62.0%
Holding current value
$560,887
Previous $292,000 81.85%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $170,479 - $210,720
434 Added 62.0%
1,134 $531,000
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $25,684 - $28,103
63 Added 9.89%
700 $292,000
Q4 2023

Feb 13, 2024

BUY
$343.0 - $410.68 $5,488 - $6,570
16 Added 2.58%
637 $259,000
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $3,043 - $3,262
9 Added 1.47%
621 $215,000
Q2 2023

Aug 11, 2023

BUY
$314.42 - $351.91 $192,425 - $215,368
612 New
612 $215,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $127B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Pgim Custom Harvest LLC Portfolio

Follow Pgim Custom Harvest LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pgim Custom Harvest LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pgim Custom Harvest LLC with notifications on news.